核蛋白3通过PI3K-Akt通路促进膀癌细胞的增殖
Linfeng Wu1, Kunyao Zhu1, Yan Sun1
1Department of Urology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Road, Yuzhong District, Chongqing, 400016, P.R. China.
World journal of surgical oncology
|November 28, 2024
概括
核蛋白3 (NOL3) 促进膀癌 (BLCA) 细胞的增殖. 抑制NOL3通过抑制PI3K/Akt通路来阻止细胞周期进展,这表明NOL3是BLCA的治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 核蛋白3 (NOL3) 在各种癌症中受到上调,并且已知具有抗亡作用.
- 新兴研究强调了NOL3在癌症转移和化学抵抗中的参与.
研究的目的:
- 研究NOL3在膀癌 (BLCA) 扩散中的作用.
- 阐明NOL3影响BLCA细胞生长的潜在分子机制.
主要方法:
- 在两个不同的BLCA细胞系中抑制NOL3表达.
- 细胞周期分析以评估增殖.
- 对PI3K/Akt信号通路的研究.
- 使用LY294002.2.对PI3K进行药理抑制.
主要成果:
- 减少NOL3显著抑制了BLCA细胞的增殖,并诱导了稳定的细胞循环停止.
- 发现PI3K/Akt通路在NOL3下降时被显著抑制.
- LY294002治疗挽救了NOL3过度表达引起的PI3K/Akt激活和扩散.
结论:
- 在BLCA中,NOL3被上调,促进癌细胞的增殖.
- NOL3通过PI3K/Akt信号通路发挥其增殖作用.
- NOL3代表了膀癌治疗的潜在治疗标.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K


